TABLE 2 from Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1&lt;sup&gt;+&lt;/sup&gt;CD8&lt;sup&gt;+&lt;/sup&gt; T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer